サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1563845

医薬品・医療機器組合せ製品の世界市場

Drug Device Combination Products

出版日
ページ情報
英文 196 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医薬品・医療機器組合せ製品の世界市場
出版日: 2024年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医薬品・医療機器組合せ製品の世界市場は2030年までに1,587億米ドルに到達

2023年に1,148億米ドルと推定された医薬品・医療機器組合せ製品の世界市場は、2030年には1,587億米ドルに達し、分析期間2023-2030年のCAGRは4.7%で成長すると予測されます。本レポートで分析したセグメントの1つである経皮パッチは、CAGR 4.5%を記録し、分析期間終了時には534億米ドルに達すると予測されます。吸入器セグメントの成長率は、分析期間中CAGR 5.8％と推定されます。

米国市場は306億米ドルと推定、中国はCAGR8.3％で成長予測

米国の医薬品・医療機器組合せ製品市場は2023年に306億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに362億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは8.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.8%と4.9%と予測されています。欧州では、ドイツがCAGR 2.1%で成長すると予測されています。

世界の医薬品・医療機器組合せ製品市場- 主要動向と促進要因まとめ

医薬品・医療機器組合せ製品とは何か、なぜ重要なのか？

医薬品・医療機器組合せ製品とは、様々な病状に対する治療の有効性、安全性、利便性を向上させるために、薬剤、デバイス、時には生物製剤を組み合わせた革新的な治療ソリューションです。これらの製品は、相乗効果による治療成績の向上、ドラッグデリバリーの標的化、放出制御、副作用の軽減などを提供するため、ヘルスケア業界においてますます重要性を増しています。一般的な例としては、薬剤溶出ステント、プレフィルドシリンジ、吸入器、経皮パッチ、薬剤コーティングを施した埋め込み型デバイスなどがあります。薬剤とデバイスの統合は、精度、管理、患者のアドヒアランスが重要な慢性疾患管理、腫瘍学、心血管治療において特に価値が高いです。個別化された効果的な治療法の需要が高まるにつれ、医薬品・医療機器組合せ製品は現代ヘルスケアに不可欠な要素となってきています。

技術の進歩は、医薬品・医療機器組合せ製品市場をどのように牽引しているのでしょうか？

技術の進歩は、医薬品・医療機器組合せ製品市場の成長と開拓を大きく後押ししています。マイクロニードルパッチ、スマート吸入器、生体吸収性ステントなどのドラッグデリバリーシステムの革新は、患者のコンプライアンスと治療効果を高めています。センサーやワイヤレス接続を含むデジタルヘルス技術の導入により、患者のアドヒアランスやドラッグデリバリーのリアルタイムモニタリングが可能になり、治療計画を最適化するための貴重なデータが医療提供者に提供されています。さらに、生体適合性ポリマーやハイドロゲルなどの新素材の開発により、埋め込み型デバイスの安全性と有効性が向上し、副作用のリスクが低減しています。また、コンビネーション製品の製造に3Dプリンティング技術を使用することで、より高度なカスタマイズと精度が可能になり、個々の患者の特定のニーズに応えることができるようになっています。このような技術の進歩は、アンメットニーズに対応する革新的なソリューションを提供することで、市場の状況を変えつつあります。

規制経路と市場力学は医薬品・医療機器組合せ製品にどのような影響を与えているか？

医薬品・医療機器組合せ製品の規制状況は複雑で、これらの製品は医薬品と医療機器の両方の規制基準を満たさなければなりません。FDAやEMAのような規制機関は、併用製品の承認プロセスを合理化し、安全性と有効性を確保しつつ、市場投入までの時間を短縮するための具体的なガイドラインを策定しつつあります。このような規制の枠組みは、配合剤の開発と商業化のための明確な道筋を提供することで、技術革新を促しています。慢性疾患の有病率の上昇、高齢化、低侵襲治療への需要といった市場力学は、医薬品・医療機器組合せ製品の採用をさらに後押ししています。また、患者中心の治療への注目の高まりや、費用対効果の高いヘルスケアソリューションの必要性も、治療結果の改善や入院期間の短縮をもたらすことから、これらの製品の使用を促進しています。

医薬品・医療機器組合せ製品市場の成長を促進する要因は？

医薬品・医療機器組合せ製品市場の成長は、技術の進歩、有利な規制環境、慢性疾患の有病率の上昇など、いくつかの要因によって牽引されています。主な促進要因は、患者のコンプライアンスと治療成績が向上する低侵襲治療に対する需要の増加です。また、デジタルヘルス技術やスマート・ドラッグデリバリー・システムの採用が拡大していることも、併用製品の有効性と利便性を高め、ヘルスケアプロバイダーと患者の双方にとってより魅力的なものとなっています。さらに、新興国市場におけるヘルスケア・インフラの拡大と個別化医療への関心の高まりが、これらの製品の開発と採用を後押ししています。製薬会社、医療機器メーカー、研究機関の戦略的提携は、技術革新と市場成長をさらに後押ししています。これらの要因は、材料科学や薬剤処方技術の絶え間ない進歩と相まって、医薬品・医療機器組合せ製品の世界市場を前進させています。

調査対象企業の例（全46件）

  • Abbott Laboratories
  • Alcon, a Novartis Company
  • Allergan PLC
  • Arrow International, Inc.
  • Bausch & Lomb, Inc.
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • CareFusion Corporation
  • Ethicon US LLC
  • Medline Industries, Inc.
  • Medtronic PLC
  • Mylan NV
  • Stryker Corporation
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP15816

Global Drug Device Combination Products Market to Reach US$158.7 Billion by 2030

The global market for Drug Device Combination Products estimated at US$114.8 Billion in the year 2023, is expected to reach US$158.7 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Transdermal Patches, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$53.4 Billion by the end of the analysis period. Growth in the Inhalers segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$30.6 Billion While China is Forecast to Grow at 8.3% CAGR

The Drug Device Combination Products market in the U.S. is estimated at US$30.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$36.2 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Drug Device Combination Products Market - Key Trends & Drivers Summarized

What Are Drug Device Combination Products And Why Are They Important?

Drug device combination products are innovative therapeutic solutions that combine drugs, devices, and sometimes biologics to improve the efficacy, safety, and convenience of treatment for various medical conditions. These products are increasingly gaining importance in the healthcare industry as they offer enhanced treatment outcomes through synergistic effects, providing targeted drug delivery, controlled release, and reduced side effects. Common examples include drug-eluting stents, prefilled syringes, inhalers, transdermal patches, and implantable devices with drug coatings. The integration of drugs and devices is particularly valuable in chronic disease management, oncology, and cardiovascular treatments, where precision, control, and patient adherence are critical. As the demand for personalized and effective treatment options grows, drug device combination products are becoming an essential component of modern healthcare.

How Are Technological Advancements Driving The Drug Device Combination Products Market?

Technological advancements are significantly driving the growth and development of the drug device combination products market. Innovations in drug delivery systems, such as microneedle patches, smart inhalers, and bioresorbable stents, are enhancing patient compliance and therapeutic effectiveness. The incorporation of digital health technologies, including sensors and wireless connectivity, is enabling real-time monitoring of patient adherence and drug delivery, providing valuable data to healthcare providers for optimizing treatment plans. Additionally, the development of novel materials, such as biocompatible polymers and hydrogels, is improving the safety and efficacy of implantable devices, reducing the risk of adverse reactions. The use of 3D printing technology in manufacturing combination products is also allowing for greater customization and precision, catering to the specific needs of individual patients. These technological advancements are transforming the market landscape by offering innovative solutions that address unmet clinical needs.

How Are Regulatory Pathways And Market Dynamics Impacting Drug Device Combination Products?

The regulatory landscape for drug device combination products is complex, as these products must meet the standards of both drug and device regulations. Regulatory bodies such as the FDA and EMA are increasingly developing specific guidelines to streamline the approval process for combination products, ensuring safety and efficacy while reducing time to market. These regulatory frameworks are encouraging innovation by providing clearer pathways for the development and commercialization of combination products. Market dynamics, such as the rising prevalence of chronic diseases, the aging population, and the demand for minimally invasive treatments, are further driving the adoption of drug device combination products. The increasing focus on patient-centric care and the need for cost-effective healthcare solutions are also promoting the use of these products, as they offer improved treatment outcomes and reduced hospital stays.

What Factors Are Driving The Growth Of The Drug Device Combination Products Market?

The growth in the drug device combination products market is driven by several factors, including technological advancements, favorable regulatory environments, and the rising prevalence of chronic diseases. A key driver is the increasing demand for minimally invasive treatments that offer better patient compliance and outcomes. The growing adoption of digital health technologies and smart drug delivery systems is also enhancing the effectiveness and convenience of combination products, making them more attractive to both healthcare providers and patients. Additionally, the expansion of healthcare infrastructure in emerging markets and the increasing focus on personalized medicine are supporting the development and adoption of these products. Strategic collaborations between pharmaceutical companies, medical device manufacturers, and research institutions are further propelling innovation and market growth. These factors, coupled with the continuous advancement of materials science and drug formulation technologies, are driving the global market for drug device combination products forward.

Select Competitors (Total 46 Featured) -

  • Abbott Laboratories
  • Alcon, a Novartis Company
  • Allergan PLC
  • Arrow International, Inc.
  • Bausch & Lomb, Inc.
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • CareFusion Corporation
  • Ethicon US LLC
  • Medline Industries, Inc.
  • Medtronic PLC
  • Mylan NV
  • Stryker Corporation
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Drug Device Combination Products - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Minimally Invasive Treatment Solutions
    • Increasing Adoption of Drug-Eluting Stents and Implantable Devices
    • Technological Advancements in Drug Delivery Mechanisms for Enhanced Efficacy
    • Growing Focus on Patient-Centric and Personalized Healthcare Solutions
    • Expansion of Applications for Combination Products in Chronic Disease Management
    • Impact of Regulatory Approvals and Fast-Track Designations on Market Growth
    • Increasing Collaborations Between Pharmaceutical and Medical Device Companies
    • Development of Smart Drug Device Combinations with Digital Health Integration
    • Rising Demand for Biodegradable and Implantable Drug Delivery Systems
    • Impact of Aging Population and Growing Burden of Chronic Diseases
    • Growing Investments in R&D for Novel Combination Products
    • Emerging Opportunities in Emerging Markets for Drug Device Combinations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Drug Device Combination Products Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Drug Device Combination Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Transdermal Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Transdermal Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Transdermal Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Drug Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Prefilled Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Prefilled Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Prefilled Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Photodynamic Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Photodynamic Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Photodynamic Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Nebulizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Nebulizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Nebulizers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Antimicrobial Wound Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Antimicrobial Wound Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Antimicrobial Wound Dressings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Home Care Setting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Home Care Setting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Home Care Setting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Drug Device Combination Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Italy 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 95: UK Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: UK Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: UK 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Spain 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 101: Spain Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Spain Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Spain 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Russia 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 107: Russia Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Russia Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Russia 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Europe 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Drug Device Combination Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Asia-Pacific 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Australia 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 128: Australia Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Australia Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Australia 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 131: India Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: India 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 134: India Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: India Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: India 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: South Korea 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 140: South Korea Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: South Korea Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: South Korea 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of Asia-Pacific Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of Asia-Pacific 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Drug Device Combination Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Latin America 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Latin America 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Argentina 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 161: Argentina Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Argentina Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Argentina 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Brazil 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 167: Brazil Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Brazil Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Brazil 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Mexico 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 173: Mexico Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Mexico Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Mexico 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Rest of Latin America 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Latin America Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Latin America 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Drug Device Combination Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Middle East 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Middle East 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Iran 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 194: Iran Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Iran Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Iran 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Israel 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 200: Israel Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Israel Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Israel 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Saudi Arabia 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Saudi Arabia Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Saudi Arabia 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: UAE 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 212: UAE Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: UAE Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: UAE 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Rest of Middle East 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Rest of Middle East Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Rest of Middle East 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Africa 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
    • TABLE 224: Africa Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Africa Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Africa 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION